Company Description
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients.
It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body.
It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody.
The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025.
INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
| Country | United States |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 37 |
| CEO | Steven Shum |
Contact Details
Address: 5582 Broadcast Court Sarasota, Florida 34240 United States | |
| Phone | 978 878 9505 |
| Website | invobioscience.com |
Stock Details
| Ticker Symbol | IVF |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001417926 |
| CUSIP Number | 44984F708 |
| ISIN Number | US44984F7087 |
| Employer ID | 20-4036208 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Steven M. Shum | Chief Executive Officer and Director |
| Dr. Daniel Gedeon Teper MBA, PharmD | President and Director |
| Andrea Goren | Chief Financial Officer |
| Lyn Falconio | Chief Communications Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 14, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Oct 10, 2025 | 8-K | Current Report |
| Oct 3, 2025 | 8-K | Current Report |
| Sep 29, 2025 | 8-K | Current Report |
| Sep 26, 2025 | 8-K | Current Report |
| Sep 12, 2025 | 8-K | Current Report |
| Sep 5, 2025 | 8-K | Current Report |
| Aug 22, 2025 | 8-K | Current Report |
| Aug 22, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Aug 15, 2025 | 8-K | Current Report |